Last updated: 2026-10-19 23:05:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Staar Surgical Co (STAA) operates in the OPHTHALMIC GOODS sector and is listed on NASDAQ. The stock is currently priced at $21.87, with a market capitalization of $1.07B and a P/E ratio of 277.82. Over the past 52 weeks, its price has ranged from $15.59 to $35.87. This page covers its latest market performance, valuation, price trends and company information.
$1.07B | |
$21.15 | |
$163.08 | |
$0.79 | |
$21.27 | |
589.42K | |
950.73K | |
277.82 | |
$35.87 | |
$15.59 | |
-- | |
-- |
Staar Surgical Co (STAA) is trading at $21.88 in after-hours trading as of 2026-10-19 19:59:53, up 2.87% ($0.61) from the regular-session close of $21.27.
After-hours trading shows how investors are pricing STAA after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Staar Surgical Co (STAA) moved from $22.38 to $21.87, representing a decline of 2.28% ($0.51).
The stock traded between $21.06 and $22.64 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 584.39 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 31.0%
STAA is currently trading at $21.87, placing it 31.0% of the way from its 52-week low of $15.59 to its 52-week high of $35.87. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
| Industry | OPHTHALMIC GOODS |
| Employees | 957 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Staar Surgical Co (STAA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.